NIH-funded research Sbir 1 grant

Long-lasting bladder treatment for urinary leaks and urgency in older adults

Official title: Novel treatment for urinary incontinence and overactive bladder symptoms in the elderly

Funded at Dignify Therapeutics, LLC · NIH-11182543 · Data updated 2026-11-12

This project is creating bladder-instilled medicines that aim to give months of relief from urinary leaks and urgent urges in older adults who haven't been helped by current treatments.

More Urinary Incontinence research and trials

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionDignify Therapeutics, LLC
NIH-funded
Lab location1 site (Research Triangle Park, United States)
Project startSeptember 5, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$110,040
NIH project number5R43AG088838-02
Project IDNIH-11182543 on NIH RePORTER

Who could benefit from this research

Could help

Older adults with urinary incontinence or overactive bladder symptoms who have not responded to standard treatments, including those in assisted living or with cognitive impairment, would be the most relevant candidates.

Less likely to help

People whose leakage is caused primarily by structural bladder abnormalities, active urinary infection, or who cannot tolerate bladder instillations may not benefit from this approach.

What this research studies

Researchers are developing drug formulations that are placed directly into the bladder to block the nerve endings that cause urgency and leakage. They plan to make formulations that stay active for more than three months and will test the drugs in lab and preclinical models before moving toward patient testing. Delivering the drug directly into the bladder is intended to concentrate effect at the target and reduce side effects throughout the body. If the approach works, it could offer a longer-lasting option for people, including those with dementia, who do not respond to current therapies.

Why it matters

Potential benefit: Could provide months-long relief of incontinence and urgency with fewer systemic side effects, easing caregiver burden and potentially reducing nursing home placement.

How similar studies have gone: Local bladder treatments (for example botulinum injections or short-acting instillations) have helped some patients before, but the specific long-lasting nociceptor-blocking formulations proposed here are novel and less tested in people.

Where this research is happening

  • Dignify Therapeutics, LLC
    Research Triangle Park, United States
    Active

Researchers

  • Principal investigator: Zhang, Qiaojuan — Dignify Therapeutics, LLC
  • Study coordinator: Zhang, Qiaojuan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.